Afya (NASDAQ:AFYA) Rating Lowered to Neutral at Bank of America

Afya (NASDAQ:AFYA) was downgraded by Bank of America from a “buy” rating to a “neutral” rating in a report released on Tuesday, MarketBeat.com reports. They currently have a $17.00 target price on the stock, down from their prior target price of $22.00. Bank of America‘s price objective suggests a potential upside of 22.04% from the company’s previous close.

A number of other research analysts also recently issued reports on AFYA. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Afya in a report on Wednesday, January 21st. Wall Street Zen downgraded Afya from a “strong-buy” rating to a “buy” rating in a research note on Saturday, January 31st. UBS Group reissued a “neutral” rating and set a $16.00 price target (down previously from $18.00) on shares of Afya in a report on Friday, January 16th. Zacks Research downgraded shares of Afya from a “hold” rating to a “strong sell” rating in a report on Friday, January 9th. Finally, JPMorgan Chase & Co. reissued a “neutral” rating and issued a $22.00 price target (down from $24.50) on shares of Afya in a report on Wednesday, January 7th. One analyst has rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $17.30.

Afya Price Performance

Shares of NASDAQ AFYA opened at $13.93 on Tuesday. The firm has a market cap of $1.31 billion, a P/E ratio of 10.02, a PEG ratio of 0.52 and a beta of 0.50. Afya has a twelve month low of $13.12 and a twelve month high of $19.90. The company has a quick ratio of 0.98, a current ratio of 0.98 and a debt-to-equity ratio of 0.21. The company has a 50 day moving average of $14.72 and a 200 day moving average of $14.89.

Institutional Trading of Afya

Several hedge funds and other institutional investors have recently added to or reduced their stakes in AFYA. Doma Perpetual Capital Management LLC boosted its holdings in Afya by 50.6% in the 3rd quarter. Doma Perpetual Capital Management LLC now owns 891,639 shares of the company’s stock worth $13,910,000 after buying an additional 299,419 shares during the last quarter. SPX Gestao de Recursos Ltda purchased a new position in Afya during the third quarter worth about $2,895,000. Swedbank AB grew its stake in shares of Afya by 170.3% in the 4th quarter. Swedbank AB now owns 189,200 shares of the company’s stock valued at $2,916,000 after buying an additional 119,200 shares during the period. Jump Financial LLC acquired a new stake in shares of Afya during the 2nd quarter worth approximately $731,000. Finally, Qube Research & Technologies Ltd purchased a new stake in shares of Afya during the 3rd quarter valued at approximately $610,000. Institutional investors and hedge funds own 88.02% of the company’s stock.

About Afya

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.